Previous Page  2 / 6 Next Page
Information
Show Menu
Previous Page 2 / 6 Next Page
Page Background

Volume 5 Issue 4(Suppl)

Clin Pharmacol Biopharm

ISSN: 2167-065X CPB, an open access journal

Page 20

Pharma & Clinical Pharmacy Congress 2016

November 07-09, 2016

conference

series

.com

November 07-09, 2016 Las Vegas, Nevada, USA

4

th

International

Pharma & Clinical Pharmacy Congress

Roseane Maria Maia Santos, Clin Pharmacol Biopharm 2016, 5:4(Suppl)

http://dx.doi.org/10.4172/2167-065X.C1.021

The Search for genomic markers for coffee consumption

T

he turnaround of the millennium brought us lots of expectation in terms of world market globalization economy, planet

environment preservation and energy resources to mention a few. However, one of the most important discoveries in

the science eld was the unveiling of the human genome. Since then, most of the attention has turned to understanding

the function of many genes and genomic fragments and their relationship with human pathophysiology. Much has been

accomplished so far, such as

BRCA1

and

BRCA2

markers for breast cancer;

HOXB13

gene for prostate cancer;

APOE

ε4 for

Alzheimer’s disease and many others that lead to the possibility of genetic testing to predict the risk of developing the disease,

if the mutant variant gene is expressed in the individual genome.

Co ee is the mostly widely consumed beverage worldwide with known health bene ts. e genomic approach to search

for speci c regions in the human DNA that are highly expressed within the co ee consumers is also a recent phenomenon.

Genome-wide association studies (GWAS) have identi ed a number of regions of interest associated with co ee consumption.

A consortium actually was created with the participation of researchers from all over the world, in an e ort to accelerate these

ndings. e purpose is to understand the relationship between parts of the human DNA and the increased or decreased co ee

use and its correlation with the prevention of a series of diseases as type-2 diabetes, cancers and neurodegenerative diseases

that account for the majority of the chronic disorders that a ict our post-millennium population.

Biography

Santos has completed his PhD from SUNY at Buffalo and is an Associate Professor at Department of Pharmaceutical Sciences at School of Pharmacy. She has

a company devoted to research and consultancy, Dr. Coffee in Savannah as well as a laboratory devoted to research on Coffee and health benefits. She has

published many papers, participated as peer reviewer for various journals and has written chapters and textbooks in Portuguese, English and Korean.

rsantos@southuniversity.edu

Roseane Maria Maia Santos

South University School of Pharmacy, USA